{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:20:43Z","timestamp":1791091243343,"version":"4.1.0"},"reference-count":18,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5,1]]},"abstract":"<jats:p>OBJECTIVE. By school age, 20% of children infected with congenital toxoplasmosis will have \u22651 retinochoroidal lesion. We determined which children are most at risk and whether prenatal treatment reduces the risk of retinochoroiditis to help clinicians decide about treatment and follow-up.<\/jats:p>\n               <jats:p>PATIENTS AND METHODS. We prospectively studied a cohort of children with congenital toxoplasmosis identified by prenatal or neonatal screening in 6 European countries. We determined the effects of prenatal treatment and prognostic markers soon after birth on the age at first detection of retinochoroiditis.<\/jats:p>\n               <jats:p>RESULTS. Of 281 children with congenital toxoplasmosis, 50 developed ocular disease, and 17 had recurrent retinochoroiditis during a median follow-up of 4.1 years. Prenatal treatment had no significant effect on the age at first or subsequent lesions. Delayed start of postnatal treatment did not increase retinochoroiditis, but the analysis lacked power. Older gestational age at maternal seroconversion was weakly associated with a reduced risk of retinochoroiditis. The presence of nonocular clinical manifestations of congenital toxoplasmosis at birth strongly predicted retinochoroiditis. For 92% (230 of 249) of children with no retinochoroiditis detected before 4 months of age, the probability of retinochoroiditis by 4 years was low, whether clinical manifestations were present or not 8.0%.<\/jats:p>\n               <jats:p>CONCLUSIONS. Prenatal treatment did not significantly reduce the risk of retinochoroiditis in this European cohort. If children have no retinochoroiditis in early infancy, the low risk of subsequent ocular disease may not justify postnatal treatment and repeated ophthalmic assessments during childhood. Controlled trials are needed to address the lack of evidence for the effectiveness of postnatal treatment.<\/jats:p>","DOI":"10.1542\/peds.2007-2169","type":"journal-article","created":{"date-parts":[[2008,4,22]],"date-time":"2008-04-22T00:25:00Z","timestamp":1208823900000},"page":"e1215-e1222","source":"Crossref","is-referenced-by-count":66,"title":["Predictors of Retinochoroiditis in Children With Congenital Toxoplasmosis: European, Prospective Cohort Study"],"prefix":"10.1542","volume":"121","author":[{"given":"Katherine","family":"Freeman","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooi Kuan","family":"Tan","sequence":"additional","affiliation":[{"name":"Centre for Paediatric Epidemiology and Biostatistics, University College London Institute of Child Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Prusa","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskild","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Buffolano","sequence":"additional","affiliation":[{"name":"Perinatal Infection Unit, Department of Pediatrics, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Malm","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital, Huddinge, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cortina-Borja","sequence":"additional","affiliation":[{"name":"Centre for Paediatric Epidemiology and Biostatistics, University College London Institute of Child Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Centre for Paediatric Epidemiology and Biostatistics, University College London Institute of Child Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the European Multicentre Study on Congenital Toxoplasmosis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,5,1]]},"reference":[{"key":"2021120908265871900_R1","doi-asserted-by":"crossref","unstructured":"Gras L, Wallon M, Pollak A, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centers. Acta Paediatr.\u20082005;94(12):1\u201312","DOI":"10.1111\/j.1651-2227.2005.tb01844.x"},{"key":"2021120908265871900_R2","doi-asserted-by":"crossref","unstructured":"Wallon M, Kodjikian L, Binquet C, et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics.\u20082004;113(6):1567\u20131572","DOI":"10.1542\/peds.113.6.1567"},{"key":"2021120908265871900_R3","doi-asserted-by":"crossref","unstructured":"Tan HK, Schmidt D, Stanford MR, et al. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am J Ophthalmol.\u20082007;144(5):648\u2013653","DOI":"10.1016\/j.ajo.2007.07.013"},{"key":"2021120908265871900_R4","doi-asserted-by":"crossref","unstructured":"Gilbert R, Dezateux C. Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established. Arch Dis Child.\u20082006;91(8):629\u2013631","DOI":"10.1136\/adc.2006.094870"},{"key":"2021120908265871900_R5","doi-asserted-by":"crossref","unstructured":"SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thie\u0301baut R, Leproust S, Che\u0302ne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet.\u20082007;369(9556):115\u2013122","DOI":"10.1016\/S0140-6736(07)60072-5"},{"key":"2021120908265871900_R6","doi-asserted-by":"crossref","unstructured":"Binquet C, Wallon M, Quantin C, et al. Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect.\u20082003;131(3):1157\u20131168","DOI":"10.1017\/S0950268803001316"},{"key":"2021120908265871900_R7","doi-asserted-by":"crossref","unstructured":"Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet.\u20081999;353(9167):1834\u20131837","DOI":"10.1016\/S0140-6736(98)11281-3"},{"key":"2021120908265871900_R8","doi-asserted-by":"crossref","unstructured":"Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG.\u20082003;110(2):112\u2013120","DOI":"10.1016\/S1470-0328(02)02325-X"},{"key":"2021120908265871900_R9","doi-asserted-by":"crossref","unstructured":"Thalib L, Gras L, Romand S, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG.\u20082005;112(5):567\u2013574","DOI":"10.1111\/j.1471-0528.2005.00486.x"},{"key":"2021120908265871900_R10","doi-asserted-by":"crossref","unstructured":"Therneau TM, Grambsch PM. Multiple Events Per Subject. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer-Verlag; 2000:169\u2013194","DOI":"10.1007\/978-1-4757-3294-8_8"},{"key":"2021120908265871900_R11","unstructured":"Thulliez P. Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis.\u20081992;84(suppl):43\u201345"},{"key":"2021120908265871900_R12","doi-asserted-by":"crossref","unstructured":"Gras L, Gilbert RE, Ades AE, Dunn DT. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol.\u20082001;30(6):1309\u20131330","DOI":"10.1093\/ije\/30.6.1309"},{"key":"2021120908265871900_R13","doi-asserted-by":"crossref","unstructured":"Gilbert R, Dunn D, Wallon M, et al. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect.\u20082001;127(1):113\u2013120","DOI":"10.1017\/S095026880100560X"},{"key":"2021120908265871900_R14","doi-asserted-by":"crossref","unstructured":"Gilbert RE, Harden M, Stanford MR. Antibiotics versus control for toxoplasma retinochoroiditis. Cochrane Database Syst Rev.\u20082002;(1)","DOI":"10.1002\/14651858.CD002218"},{"key":"2021120908265871900_R15","unstructured":"Daveluy A, Haramburu F, Bricout H, et al. Review of Data Related to Side Effects of Drugs Used in Congenital Toxoplasmosis. Bordeaux, France: EUROTOXO A European Consensus on the State of the Science; 2005"},{"key":"2021120908265871900_R16","doi-asserted-by":"crossref","unstructured":"Freeman K, Salt A, Prusa A, et al. Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns and impairments, in 3 year old children. BMC Pediatr.\u20082005;5:23","DOI":"10.1186\/1471-2431-5-23"},{"key":"2021120908265871900_R17","doi-asserted-by":"crossref","unstructured":"Lehmann T, Marcet PL, Graham DH, Dahl ER, Dubey JP. Globalization and the population structure of Toxoplasma gondii. Proc Natl Acad Sci USA.\u20082006;103(30):11423\u201311428","DOI":"10.1073\/pnas.0601438103"},{"key":"2021120908265871900_R18","doi-asserted-by":"crossref","unstructured":"Ajzenberg D, Banuls AL, Su C, et al. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int J Parasitol.\u20082004;34(10):1185\u20131196","DOI":"10.1016\/j.ijpara.2004.06.007"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/5\/e1215\/1175035\/zpe005080e1215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/5\/e1215\/1175035\/zpe005080e1215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T02:51:21Z","timestamp":1639104681000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/5\/e1215\/73458\/Predictors-of-Retinochoroiditis-in-Children-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,5,1]]},"published-print":{"date-parts":[[2008,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-2169","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}